Synthesis, biological evaluation and molecular docking analysis of novel benzopyrimidinone derivatives as potential anti-tyrosinase agents. 2019

Sarra Chortani, and Vijaykumar D Nimbarte, and Mabrouk Horchani, and Hichem Ben Jannet, and Anis Romdhane
University of Monastir, Faculty of Science of Monastir, Laboratory of Heterocyclic Chemistry, Natural Products and Reactivity (LR11ES39), Team: Medicinal Chemistry and Natural Products, Avenue of Environment, 5019 Monastir, Tunisia.

2-substitued-benzopyrimidinones 2 were synthesized in high to excellent yields in a single step via condensation of 2-aminobenzamide 1 with some aryl-aldehydes in the presence of iodine. Cyclocondensation reaction of hydrazides 3 which were obtained in two steps from benzopyrimidinones 2, with some electrophilic species such as 2,4-pentandione, 2,5-hexandione, 1-phenylbutan-1,3-dione and cyclic anyhdrides provided the new compounds 4a-c, 5a-c, 6a-c, 7a-c, 8a-c and 9a-c. The synthesized compounds were characterized by spectroscopic means. They were also evaluated for their anti-tyrosinase potential. The structure-activity relationship (SAR) was discussed on the basis of the molecular docking analysis.

UI MeSH Term Description Entries
D011744 Pyrimidinones Heterocyclic compounds known as 2-pyrimidones (or 2-hydroxypyrimidines) and 4-pyrimidones (or 4-hydroxypyrimidines) with the general formula C4H4N2O. Pyrimidinone,Pyrimidone,Pyrimidones
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014442 Monophenol Monooxygenase An enzyme of the oxidoreductase class that catalyzes the reaction between L-tyrosine, L-dopa, and oxygen to yield L-dopa, dopaquinone, and water. It is a copper protein that acts also on catechols, catalyzing some of the same reactions as CATECHOL OXIDASE. EC 1.14.18.1. Dopa Oxidase,Phenoloxidase,Tyrosinase,Cresolase,Phenol Oxidase,Phenoloxidase A,Phenoloxidase B,Monooxygenase, Monophenol,Oxidase, Dopa,Oxidase, Phenol
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Sarra Chortani, and Vijaykumar D Nimbarte, and Mabrouk Horchani, and Hichem Ben Jannet, and Anis Romdhane
April 2021, International journal of molecular sciences,
Sarra Chortani, and Vijaykumar D Nimbarte, and Mabrouk Horchani, and Hichem Ben Jannet, and Anis Romdhane
February 2024, ACS chemical neuroscience,
Sarra Chortani, and Vijaykumar D Nimbarte, and Mabrouk Horchani, and Hichem Ben Jannet, and Anis Romdhane
October 2022, Bioorganic chemistry,
Sarra Chortani, and Vijaykumar D Nimbarte, and Mabrouk Horchani, and Hichem Ben Jannet, and Anis Romdhane
November 2021, Molecular diversity,
Sarra Chortani, and Vijaykumar D Nimbarte, and Mabrouk Horchani, and Hichem Ben Jannet, and Anis Romdhane
June 2022, Molecules (Basel, Switzerland),
Sarra Chortani, and Vijaykumar D Nimbarte, and Mabrouk Horchani, and Hichem Ben Jannet, and Anis Romdhane
September 2010, European journal of medicinal chemistry,
Sarra Chortani, and Vijaykumar D Nimbarte, and Mabrouk Horchani, and Hichem Ben Jannet, and Anis Romdhane
January 2021, Medicinal chemistry (Shariqah (United Arab Emirates)),
Sarra Chortani, and Vijaykumar D Nimbarte, and Mabrouk Horchani, and Hichem Ben Jannet, and Anis Romdhane
January 2018, Chemical & pharmaceutical bulletin,
Sarra Chortani, and Vijaykumar D Nimbarte, and Mabrouk Horchani, and Hichem Ben Jannet, and Anis Romdhane
December 2010, Chemical biology & drug design,
Sarra Chortani, and Vijaykumar D Nimbarte, and Mabrouk Horchani, and Hichem Ben Jannet, and Anis Romdhane
October 2012, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!